VCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation

Area of Science:

• Molecular Biology
• Cell Biology
• Bone Biology

Background:

• The bone morphogenetic protein (BMP)-Smad signaling pathway is vital for bone homeostasis and osteoblast activity.
• Smad ubiquitination regulatory factor 1 (Smurf1) is a known negative regulator of BMP signaling, but its own regulatory mechanisms are unclear.
• Mutations in valosin-containing protein (VCP/p97) are linked to Paget's disease of bone (PDB)-like syndromes.

Purpose of the Study:

• To elucidate the regulatory mechanism of Smurf1 stability and activity.
• To investigate the role of VCP/p97 in the regulation of BMP signaling.
• To understand the molecular basis of VCP/p97-related bone diseases.

Main Methods:

• Co-immunoprecipitation assays to identify protein interactions.
• Western blotting to assess protein levels.
• Depletion studies using siRNA to evaluate protein function.
• ATPase activity assays to characterize VCP/p97 function.

Main Results:

• VCP/p97 and its adaptor NPL4 specifically interact with Smurf1 and promote its ubiquitination and degradation.
• Depletion of VCP/p97 or NPL4 increases Smurf1 levels and reduces BMP signaling.
• A specific motif in Smurf1 is required for VCP/p97-mediated degradation, dependent on VCP/p97 ATPase activity.
• PDB-associated VCP/p97 mutations enhance ATPase activity, leading to increased Smurf1 degradation and elevated BMP signaling.

Conclusions:

• VCP/p97 directly regulates Smurf1 stability and thereby modulates BMP signaling.
• The findings establish a novel link between VCP/p97 and Smurf1, explaining Smurf1 regulation and VCP/p97-related bone pathologies.
• This study provides a molecular mechanism for how VCP/p97 mutations contribute to bone diseases through altered BMP signaling.